Hepatitis Forums
Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on January 19, 2017, 10:39:10 am
-
Researchers have seen promising early results in a trial of two nucleic acid polymers among people with e-antigen-negative hepatitis B virus who had not been treated for HBV before, Medscape reports. These results suggest that the treatments may lead to functional control of hep B.
Scientists conducted a randomized open-label trial of 40 people with HBV who were new to treatment for the virus. The participants did not have hepatitis C or D viruses (HCV/HDV) or HIV, had serum hep B surface antigen levels above 1,000, hep B viral loads above 7,500 and mild to moderate fibrosis of the liver; none had cirrhosis.
Read more...
https://www.hepmag.com/article/promising-early-results-treatment-gain-functional-control-hep-b